MAP.AX ASX
Microba Life Sciences Limited
1W: -3.9%
1M: -10.9%
3M: +28.9%
YTD: -46.7%
1Y: -42.4%
3Y: -85.2%
A$0.05 ($0.03)
-0.00 (-2.04%)
Weekly Expected Move ±6.8%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$40M
-16.1% ▼
5Y CAGR: +16.6%
Total Liabilities
$14M
-8.3% ▼
5Y CAGR: +31.0%
Shareholders Equity
$24M
-25.0% ▼
5Y CAGR: +10.3%
Cash & Investments
$8M
-32.3% ▼
5Y CAGR: -9.4%
Total Debt
$4M
+27.1% ▲
5Y CAGR: +72.5%
Net Debt
-$4M
+54.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $31M | $32M | $21M | $12M | $8M |
| Short-Term Investments | $204K | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $31M | $32M | $21M | $12M | $8M |
| Net Receivables | $3M | $7M | $8M | $4M | $3M |
| Inventory | $360K | $644K | $2M | $2M | $2M |
| Other Current Assets | $0 | $204K | $211K | $332K | $0 |
| Total Current Assets | $36M | $42M | $32M | $19M | $14M |
| Property, Plant & Equip. | $3M | $3M | $4M | $4M | $2M |
| Goodwill & Intangibles | $854K | $3M | $22M | $25M | $23M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $265K |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $4M | $5M | $26M | $28M | $26M |
| Total Assets | $39M | $47M | $58M | $47M | $40M |
| — Liabilities — | |||||
| Accounts Payable | $813K | $3M | $4M | $2M | $3M |
| Short-Term Debt | $364K | $359K | $395K | $746K | $2M |
| Deferred Revenue | $3M | $3M | $2M | $0 | $2M |
| Other Current Liabilities | -$361K | -$327K | $5M | $3M | $3M |
| Total Current Liabilities | $5M | $8M | $12M | $10M | $11M |
| Long-Term Debt | $0 | $0 | $0 | $469K | $365K |
| Other Non-Current Liab. | $195K | $321K | $3M | $1M | $73K |
| Total Non-Current Liabilities | $679K | $404K | $4M | $5M | $3M |
| Total Liabilities | $6M | $8M | $17M | $15M | $14M |
| — Equity — | |||||
| Common Stock | $63M | $80M | $103M | $109M | $120M |
| Retained Earnings | -$31M | -$44M | -$64M | -$79M | -$99M |
| Accumulated OCI | $2M | $2M | $2M | $3M | $3M |
| Total Stockholders Equity | $34M | $39M | $41M | $32M | $24M |
| Total Liabilities & Equity | $39M | $47M | $58M | $47M | $40M |
| — Key Metrics — | |||||
| Total Debt | $1M | $1M | $2M | $3M | $4M |
| Net Debt | -$29M | -$31M | -$19M | -$9M | -$4M |
| Total Investments | $204K | $0 | $0 | $0 | $265K |